{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:34:26Z","timestamp":1790710466715,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"DOI":"10.1093\/ehjcvp\/pvy022","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T11:08:14Z","timestamp":1532171294000},"page":"21-28","source":"Crossref","is-referenced-by-count":30,"title":["A randomized, double-blind, placebo-controlled trial assessing the efficacy of S66913 in patients with paroxysmal atrial fibrillation"],"prefix":"10.1093","volume":"5","author":[{"given":"A John","family":"Camm","sequence":"first","affiliation":[{"name":"Molecular and Clinical Sciences Research Institute, Cardiology Clinical Academic Group, St George's University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Dorian","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, and Division of Cardiology, St. Michael's Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H","family":"Hohnloser","sequence":"additional","affiliation":[{"name":"Division of Clinical Electrophysiology, Department of Cardiology, J. W. Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R","family":"Kowey","sequence":"additional","affiliation":[{"name":"Lankenau Medical Center, Lankenau Institute of Medical Research, Wynnewood, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Tyl","sequence":"additional","affiliation":[{"name":"Cardiovascular Center for Therapeutic Innovation, Institut de Recherches Internationales Servier, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbin","family":"Ni","sequence":"additional","affiliation":[{"name":"Cardiovascular Center for Therapeutic Innovation, Institut de Recherches Internationales Servier, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Vandzhura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center for Therapeutic Innovation, Institut de Recherches Internationales Servier, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Maison-Blanche","sequence":"additional","affiliation":[{"name":"Cardiabase, Nancy, France"},{"name":"AP-HP, H\u00f4pital Bichat, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"de Melis","sequence":"additional","affiliation":[{"name":"Medtronic Bakken Research Center, Endepolsdomein 5, Maastricht, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Centre for Heart Rhythm Disorders, South Australian Health and Medical Research Institute, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B1","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10840-011-9601-1","article-title":"Progression of new onset to established persistent atrial fibrillation: an implantable device-based analysis with implications for clinical classification of persistent atrial fibrillation","volume":"32","author":"Nagarakanti","year":"2011","journal-title":"J Interv Card Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1517\/13543780902762850","article-title":"I(Kur)\/Kv1.5 channel blockers for the treatment of atrial fibrillation","volume":"18","author":"Tamargo","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B5","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.drudis.2012.02.007","article-title":"New pharmacological approaches to atrial fibrillation","volume":"17","author":"Milnes","year":"2012","journal-title":"Drug Discov Today"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.hrthm.2015.10.003","article-title":"The positive frequency-dependent electrophysiological effects of the IKur inhibitor XEN-D0103 are desirable for the treatment of atrial fibrillation","volume":"13","author":"Ford","year":"2016","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/europace\/eum191","article-title":"Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association","volume":"9","author":"Kirchhof","year":"2007","journal-title":"Europace"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/europace\/eun384","article-title":"A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology","volume":"11","author":"Arya","year":"2008","journal-title":"Europace"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10840-011-9636-3","article-title":"A randomized trial of budiodarone in paroxysmal atrial fibrillation","volume":"34","author":"Ezekowitz","year":"2012","journal-title":"J Interv Card Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/CIRCEP.115.002856","article-title":"The HARMONY trial: combined ranolazine and dronedarone in the management of paroxysmal atrial fibrillation: mechanistic and therapeutic synergism","volume":"8","author":"Reiffel","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCEP.109.877852","article-title":"Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial","volume":"3","author":"Hindricks","year":"2010","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2016.03.005","article-title":"Performance of a new atrial fibrillation detection algorithm in a miniaturized insertable cardiac monitor: results from the Reveal LINQ Usability Study","volume":"13","author":"Sanders","year":"2016","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/CIRCEP.108.812347","article-title":"Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale","volume":"2","author":"Dorian","year":"2009","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(00)00886-X","article-title":"The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy","volume":"36","author":"Dorian","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10840-014-9966-z","article-title":"A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers","volume":"42","author":"Ezekowitz","year":"2015","journal-title":"J Interv Card Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B16","author":"International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH harmonised tripartite guideline)","year":"2017"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.addr.2016.01.018","article-title":"Molecular inflation, attrition and the rule of five","volume":"101","author":"Leeson","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/FJC.0000000000000277","article-title":"Novel K+ channel targets in atrial fibrillation drug development\u2014where are we?","volume":"66","author":"El-Haou","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/europace\/euv263","article-title":"First clinical trial of specific IKACh blocker shows no reduction in atrial fibrillation burden in patients with paroxysmal atrial fibrillation: pacemaker assessment of BMS 914392 in patients with paroxysmal atrial fibrillation","volume":"18","author":"Podd","year":"2016","journal-title":"Europace"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0026-895X(25)09019-4","article-title":"High affinity open channel block by dofetilide of HERG expressed in a human cell line","volume":"49","author":"Snyders","year":"1996","journal-title":"Mol Pharmacol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.hrthm.2006.07.030","article-title":"Comparison of continuous versus intermittent monitoring of atrial arrhythmias","volume":"3","author":"Ziegler","year":"2006","journal-title":"Heart Rhythm"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B22","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B23","author":"CHMP","year":"2017"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10840-018-0318-2","article-title":"A double-blind, randomised, placebo-controlled, cross-over study assessing the use of XEN-D0103 in patients with paroxysmal atrial fibrillation and implanted pacemakers allowing continuous beat-to-beat monitoring of drug efficacy","volume":"51","author":"Shunmugam","year":"2018","journal-title":"J Interv Card Electrophysiol"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/europace\/eus223","article-title":"Sinus node dysfunction and atrial fibrillation: two sides of the same coin?","volume":"15","author":"Lee","year":"2013","journal-title":"Europace"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/01.CIR.0000109490.72104.EE","article-title":"Canadian Trial of Physiological Pacing: effects of physiological pacing during long-term follow-up","volume":"109","author":"Kerr","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B27","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1161\/01.CIR.0000072769.17295.B1","article-title":"Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction","volume":"107","author":"Sweeney","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010703593633600_pvy022-B28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/pace.12897","article-title":"Continuous cardiac monitoring around atrial fibrillation ablation: insights on clinical classifications and end points","volume":"39","author":"Dekker","year":"2016","journal-title":"Pacing Clin Electrophysiol"}],"container-title":["European Heart Journal - Cardiovascular Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcvp\/article-pdf\/5\/1\/21\/27418272\/pvy022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T23:12:29Z","timestamp":1751757149000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcvp\/article\/5\/1\/21\/5057520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,7,23]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcvp\/pvy022","relation":{},"ISSN":["2055-6837","2055-6845"],"issn-type":[{"value":"2055-6837","type":"print"},{"value":"2055-6845","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,7,23]]}}}